Isolation, Propagation, and Characterization of Human Umbilical Cord Perivascular Cells (HUCPVCs)

  • Rahul Sarugaser
  • Jane Ennis
  • William L. Stanford
  • John E. Davies
Part of the Methods in Molecular Biology book series (MIMB, volume 482)


Current sources of mesenchymal cells, including bone marrow, fat and muscle, all require invasive procurement procedures, and provide relatively low frequencies of progenitors. Here, we describe the non-invasive isolation, and characterization, of a rich source of mesenchymal progenitor cells, which we call human umbilical cord perivascular cells (HUCPVCs). HUCPVCs show a similar immunological phenotype to bone marrow-derived mesenchymal stromal cells (BM-MSCs), since they are non-alloreactive, exhibit immunosuppression, and significantly reduce lymphocyte activation, in vitro. They present a non-hematopoietic myofibroblastic mesenchymal phenotype (CD45-, CD34-, CD105+, CD73+, CD90+, CD44+, CD106+, 3G5+, CD146+); with a 1:300 frequency at harvest, a short-doubling time, and a clonogenic frequency of >1:3 in culture. Furthermore, in addition to robust quinti-potential differentiation capacity in vitro, HUCPVCs have been shown to contribute to both musculo-skeletal and dermal wound healing in vivo.

Key words

Mesenchymal progenitor cell mesenchymal stem cell umbilical cord 


  1. 1.
    Caplan, A.I., Mesenchymal stem cells. J. Orthop. Res, 1991. 9(5): 641–650.CrossRefPubMedGoogle Scholar
  2. 2.
    Sarugaser, R., et al., Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells, 2005. 23(2): 220–229.CrossRefPubMedGoogle Scholar
  3. 3.
    Kogler, G., et al., A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J. Exp. Med., 2004. 200(2): 123–135.CrossRefPubMedGoogle Scholar
  4. 4.
    Nayak, R.C., et al., A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes. J. Exp. Med., 1988. 167(3): 1003–1015.CrossRefPubMedGoogle Scholar
  5. 5.
    Baksh, D., et al., Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells, 2007. 45(67): 99–106.Google Scholar
  6. 6.
    Le Blanc, K., Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy, 2003. 5(6): 485–489.CrossRefPubMedGoogle Scholar
  7. 7.
    Ennis, J, et al., In vitro immunologic properties of human umbilical cord perivascular cells. Cytotherapy, 2008. 10(2): 174–181.CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Rahul Sarugaser
    • 1
  • Jane Ennis
    • 1
  • William L. Stanford
    • 1
  • John E. Davies
    • 1
  1. 1.Institute of Biomaterials and Biomedical Engineering, University of TorontoTorontoCanada

Personalised recommendations